Apogee Therapeutics announced the appointment of Mark McKenna as Chairman of its board of directors. McKenna’s knowledge and successful track record in the I&I space as well as his significant development, commercial and executive management experience contributed to the Apogee board of directors’ selection decision. McKenna is the former President, Chief Executive Officer and Chairman of the board of directors of Prometheus Biosciences.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on APGE:
- Apogee Therapeutics Appoints Mark C. McKenna, Healthcare Veteran and Former Chairman, President and CEO of Prometheus Biosciences, as Chairman of its Board
- DraftKings upgraded, Home Depot downgraded: Wall Street’s top analyst calls
- Apogee Therapeutics initiated with an Outperform at TD Cowen
- Wedbush bullish on Apogee Therapeutics, initiates with an Outperform
- 3 Best Stocks to Buy Now, 8/8/2023, According to Top Analysts